Microplate Dx logo

Microplate Dx

Recent Finacing

Seed

Recent Raise

$3.1M


Glasgow diagnostics spinout Microplate Dx has closed a £2.5 million seed funding round to develop its point-of-care diagnostic platform, which can confirm the presence of bacteria and rapidly identify effective antibiotics to use and which ones to avoid.

Total Funding

$3.1M

Headquarters

Glasgow, United Kingdom

Founded

2022

Focus Areas

Diagnostics Technology
Point-of-Care Diagnostics
Antibiotic Resistance

Investors